This announcement is a separate document:
中信建投证券股份有限公司关于科兴生物制药股份有限公司首次公开发行股票并在科创板上市之保荐总结报告书
CITIC Construction Investment Securities Co., Ltd.'s sponsorship summary report on the initial public offering of shares of Kexing Biopharmaceutical Co., Ltd. and its listing on the Science and Technology Innovation Board
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.